Harrow Plans Add-On Offering of $50 Million of Senior Unsecured Notes

Published on March 25, 2026
NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, announced that it plans to offer an additional $50 million in aggregate principal amount of its 8.625 percent senior unsecured notes due 2030, subject to market conditions. The newly issued 2030 Notes will be part of the same series as the existing $250,000,000 aggregate principal amount of 2030 Notes, which were issued on September 12, 2025. Harrow confirmed that the additional notes will be governed by the original indenture and will share all terms with the existing notes, except for the date of issuance and the issue price.